← FDA Drug Approvals (Drugs@FDA)

AMIFOSTINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2017-07-17

Drug application

FDA Application #

ANDA204363

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMIFOSTINE

Generic name

Amifostine

Active ingredients

AMIFOSTINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

EUGIA PHARMA SPECLTS

First approval

2017-07-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown